Corrigendum: Experimental validation of immunogenic SARS-CoV-2 T cell epitopes identified by artificial intelligence.

CD4+ lymphocytes CD8+ lymphocytes COVID-19 SARS-CoV-2 T cell antigen (Ag) artificial intelligence vaccine

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2024
Historique:
received: 26 01 2024
accepted: 05 02 2024
medline: 7 3 2024
pubmed: 7 3 2024
entrez: 7 3 2024
Statut: epublish

Résumé

[This corrects the article DOI: 10.3389/fimmu.2023.1265044.].

Identifiants

DOI: 10.3389/fimmu.2024.1377041 PMID: 38449865 PMC: PMC10916508
pubmed: 38449865
doi: 10.3389/fimmu.2024.1377041
pmc: PMC10916508
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

1377041

Commentaires et corrections

Type : ErratumFor

Informations de copyright

Copyright © 2024 Federico, Malone, Tennøe, Chaban, Osen, Gainullin, Smorodina, Kared, Akbar, Greiff, Stratford, Clancy and Munthe.

Auteurs

Lorenzo Federico (L)

Department of Immunology, Oslo University Hospital, Oslo, Norway.
KG Jebsen Centre for B cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Brandon Malone (B)

NEC OncoImmunity AS, Oslo, Norway.

Simen Tennøe (S)

NEC OncoImmunity AS, Oslo, Norway.

Viktoriia Chaban (V)

Department of Immunology, Oslo University Hospital, Oslo, Norway.
KG Jebsen Centre for B cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Julie Røkke Osen (JR)

Department of Immunology, Oslo University Hospital, Oslo, Norway.
KG Jebsen Centre for B cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Murat Gainullin (M)

Department of Immunology, Oslo University Hospital, Oslo, Norway.
KG Jebsen Centre for B cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Eva Smorodina (E)

Department of Immunology, Oslo University Hospital, Oslo, Norway.
Institute of Clinical Medicine, Oslo University Hospital, Oslo, Norway.

Hassen Kared (H)

Department of Immunology, Oslo University Hospital, Oslo, Norway.
KG Jebsen Centre for B cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Rahmad Akbar (R)

Department of Immunology, Oslo University Hospital, Oslo, Norway.
Institute of Clinical Medicine, Oslo University Hospital, Oslo, Norway.

Victor Greiff (V)

Department of Immunology, Oslo University Hospital, Oslo, Norway.
Institute of Clinical Medicine, Oslo University Hospital, Oslo, Norway.

Richard Stratford (R)

NEC OncoImmunity AS, Oslo, Norway.

Trevor Clancy (T)

NEC OncoImmunity AS, Oslo, Norway.

Ludvig Andre Munthe (LA)

Department of Immunology, Oslo University Hospital, Oslo, Norway.
KG Jebsen Centre for B cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Classifications MeSH